The House of Representatives has included a 2.5% federal excise tax on medical products distributors within healthcare reform legislation. The Affordable Health Care for America Act (H.R. 3962) adopted a Senate proposal for a medical device tax, but applies the fee annually on distributors by taxing at the point of sale of products to providers. HIDA strongly opposes this tax and we urge all members to contact their members of Congress as soon as possible - votes on this language may take place as early as next week.
The core arguments against this tax structure are: 1) a healthcare distribution industry earning 1.3% annual profits cannot pay a 2.5% annual tax 2) distributors should not bear the burden of a tax intended to be levied on manufacturers and 3) the tax burden will inevitably shift to hospitals and doctors
HIDA is proactively meeting with key committees to advocate against the tax, coordinating with members who have existing Congressional relationships, and sending letters to targeted leadership offices. Most importantly, HIDA members must contact Congress (both in the Senate and House of Representatives) and urge them to advocate for a manufacturer tax structure that doesn't "pass" the tax burden along to distributors and providers.
Thank you for your involvement and support. If you have any questions. please contact Andrew E. Van Ostrand, Vice President of Policy & Research at vanostrand@hida.org.